Showing results (301-310 of 317) with videos related to
Sort By:
Pageof 32
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.Nature Machine Intelligence|September 25, 2025
Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical researchArtem A Trotsyuk, Quinn Waeiss, Raina Talwar Bhatia, et al.Science Translational Medicine|July 31, 2020
Scientific considerations for global drug developmentJennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, et al.Nature Genetics|October 19, 2023
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseasesMargaret G Guo, David L Reynolds, Cheen E Ang, et al.JAMA|March 13, 2014
Clinical interpretation and implications of whole-genome sequencingFrederick E Dewey, Megan E Grove, Cuiping Pan, et al.Plos One|November 14, 2013
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizesElijah R Behr, Marylyn D Ritchie, Toshihiro Tanaka, et al.Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.Frontiers in Psychiatry|March 22, 2018
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 6, 2019
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.Pageof 32